Regulatory

The judge’s condemnation of DMAA suggests weaknesses in the FDA’s New Dietary Ingredient guidance.

Fifteen (or roughly 25 percent) of the 59 New Dietary Ingredient (NDI) notifications submitted to the Food and Drug Administration (FDA) between November 2015 and October 2016 were acknowledged without objection, according to the latest data...

Critics say the traffic cop solution is unfairly imposing pharmacy monitoring model to supplements.

Trade group heads perceive openness to innovation from nominee Scott Gottlieb.

Suing critics goes against the movement toward transparency.

The Trump administration has indicated a mission to eliminate regulations, but public safety concerns could stall deregulation at the FDA.

With the Affordable Care Act repeal on the docket, Congressional Dietary Supplement Caucus looks to promote vitamin businesses.

The war on (some) drugs continues apace. Or is this just a simple administrative maneuver that has everyone paranoid?

As proposed by FDA, the New Dietary Ingredient guidance document could upend the ingredients and supplements world more profoundly than anything this side of 1994's DSHEA.

The FDA opens its Adverse Event Report data with little context and no causality.